|
ZNF702P expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.824000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.095500E-02 |
| Normal-vs-Stage2 |
9.090600E-01 |
| Normal-vs-Stage3 |
3.268200E-01 |
| Normal-vs-Stage4 |
5.136800E-01 |
| Stage1-vs-Stage2 |
2.101400E-01 |
| Stage1-vs-Stage3 |
3.062400E-01 |
| Stage1-vs-Stage4 |
2.720600E-01 |
| Stage2-vs-Stage3 |
5.550000E-01 |
| Stage2-vs-Stage4 |
6.945800E-01 |
| Stage3-vs-Stage4 |
8.570600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.204000E-02 |
| Normal-vs-AfricanAmerican |
8.298800E-01 |
| Normal-vs-Asian |
1.790240E-01 |
| Caucasian-vs-AfricanAmerican |
5.257800E-01 |
| Caucasian-vs-Asian |
8.682000E-01 |
| AfricanAmerican-vs-Asian |
4.852400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.233400E-01 |
| Normal-vs-Female |
2.783800E-02 |
| Male-vs-Female |
7.808300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.033870E-02 |
| Normal-vs-Age(41-60Yrs) |
3.326000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.054400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.926600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.517800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.264300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.727600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.650000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.525800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.776600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.582800E-01 |
| Classical-VS-Follicular |
5.731600E-02 |
| Classical-VS-Other |
3.200200E-01 |
| Classical-VS-Normal |
1.361980E-02 |
| Tall-VS-Follicular |
1.341650E-01 |
| Tall-VS-Other |
1.949590E-01 |
| Tall-VS-Normal |
8.164400E-02 |
| Follicular-VS-Other |
7.006200E-01 |
| Follicular-VS-Normal |
9.796000E-01 |
| Other-VS-Normal |
5.385200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.449590E-01 |
| Normal-vs-N1 |
4.778200E-01 |
| N0-vs-N1 |
9.308000E-01 |
|
|
